India on Saturday flagged off world's largest vaccination drive against coronavirus. The first vaccine shots were given to nearly two lakh frontline healthcare and sanitary workers as Prime Minister Narendra Modi rolled out the world’s largest inoculation drive against the pandemic that has caused 1,52,093 deaths and upended millions of lives in the country.
Uttar Pradesh Chief Minister Yogi Adityanath on Saturday asked the people to remain alert for rumours regarding COVID-19 vaccines and wait for their turn to get themselves vaccinated.
AIIMS Director Dr Randeep Guleria on Saturday joined scores of healthcare workers across the country who were administered Covid-19 vaccine shots on the first day of the nationwide vaccination drive.
Amid the rollout of the world's largest Covid-19 vaccination programme by Prime Minister Narendra Modi, here are a few things that you need to know about the two vaccines -- 'Covaxin' and 'Covishield' -- selected by the Drugs Controller General of India (DCGI).
Bharat Biotech, which has received a government purchase order for supply of 55 lakh doses of Covaxin, a COVID-19 vaccine, said the company will pay compensation to recipients in case of any serious adverse effects experienced after receiving the antidote.
Punjab Chief Minister Amarinder Singh on Friday wrote to Prime Minister Narendra Modi, seeking free COVID-19 vaccination for the poor in the state.
Prime Minister Narendra Modi on Saturday will kick start the world's largest vaccination drive against coronavirus, almost a year after India reported the first case of the deadly infectious disease, which has claimed over 1.5 lakh lives in the country till now. It is going to be a historic moment with the commencement of the eagerly-awaited vaccination drive against the dreaded disease.
As country after country approves vaccine to fight coronavirus, India's neighbour Nepal has also approved use of AstraZeneca Covishield vaccine manufactured in India, Reuters reported quoting Nepal Government.
Brazil is planning to send a special flight to Mumbai to lift at least two million doses of Covid-19 vaccine.
According to the Union Health Ministry, the comparison parameters will include vaccine platform, physical specifications, dosage, cold chain storage requirements, and minor adverse events following the immunisation.
At the same time, another Corona vaccine, Covishield by Serum Institute of India (SII), was permitted to people above 18 years of age, permission letter to the SII showed.
The Delhi government is expecting to scale up the vaccination centres to 225 within a week of the Covid-19 immunisation programme launch, officials informed.
As vaccines against coronavirus reaching corners of India during mass distribution drive underway ahead of January 16 launch, the robust preparations ahead of the D-day when the world's biggest immunization exercise against the Covid-19 starts, are underway at the national capital too.
At a time when vaccine distribution to states across India is in full swing ahead of the January 16 launch, the Congress party has raised questions on the safety, compatibility of India's homegrown Covid vaccine named COVAXIN, asking the government how it can be rolled out when it is yet to clear phase-3 trials.
The first batch of Covaxin, Covid-19 vaccine by Bharat Biotech, landed at the Delhi airport from Hyderabad on Wednesday morning.
The first phase of the COVID-19 vaccination drive is scheduled to start from January 16. Health Secretary Rajesh Bhushan said that the Central government is having a close collaboration with states and union territories for vaccine roll-out.
Bharat Biotech on Tuesday announced it has signed an agreement with Precisa Medicamentos for the supplies of its Covid vaccine 'Covaxin' to Brazil.
Today we have received the first consignment ofvaccines from Serum Institute at Hyderabad airport. We received 970 kgs of consignment from Serum Institute. Today in the evening the first consignment is goingout of Hyderabad.
Chhattisgarh Health Minister TS Singh Deo on Saturday said the use of COVID-19 vaccine `Covaxin' must not be allowed in the state as its third-phase trial data has not been published yet.
Almost a year into the COVID-19 pandemic, about 200 vaccine candidates are in the works and 10 have been either approved by several countries or are under limited emergency use.
Top News
Latest News
